| __timestamp | Alkermes plc | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 170914000 | 1162636000 |
| Thursday, January 1, 2015 | 144942000 | 1396725000 |
| Friday, January 1, 2016 | 226424000 | 1526100000 |
| Sunday, January 1, 2017 | 335737000 | 1619600000 |
| Monday, January 1, 2018 | 492448000 | 1429100000 |
| Tuesday, January 1, 2019 | 477729000 | 1331200000 |
| Wednesday, January 1, 2020 | 465852000 | 1375200000 |
| Friday, January 1, 2021 | 569838000 | 1563000000 |
| Saturday, January 1, 2022 | 893687000 | 1789600000 |
| Sunday, January 1, 2023 | 1410368000 | 2070000000 |
| Monday, January 1, 2024 | 1312301000 |
Data in motion
Over the past decade, United Therapeutics Corporation and Alkermes plc have showcased intriguing trajectories in their gross profit margins. From 2014 to 2023, United Therapeutics consistently outperformed Alkermes, with a gross profit increase of approximately 78%, peaking at $2.07 billion in 2023. In contrast, Alkermes experienced a remarkable surge, growing its gross profit by over 700% during the same period, reaching $1.41 billion in 2023.
This financial journey highlights United Therapeutics' steady dominance, while Alkermes' rapid growth trajectory underscores its potential in the pharmaceutical sector. The data reveals a compelling narrative of strategic growth and market positioning, offering valuable insights for investors and industry analysts alike. As these companies continue to innovate, their financial performance will be a key indicator of their future success.
Bristol-Myers Squibb Company vs United Therapeutics Corporation: A Gross Profit Performance Breakdown
Gross Profit Comparison: Regeneron Pharmaceuticals, Inc. and Alkermes plc Trends
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or United Therapeutics Corporation
Biogen Inc. and United Therapeutics Corporation: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? United Therapeutics Corporation or Genmab A/S
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Alkermes plc
United Therapeutics Corporation vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Incyte Corporation and Alkermes plc
Jazz Pharmaceuticals plc vs Alkermes plc: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Alkermes plc vs Bausch Health Companies Inc.
Alkermes plc and Vericel Corporation: A Detailed Gross Profit Analysis